2-FA: Difference between revisions
>Unity m Grammatics |
>Denada m Removed the claim that 2-fa is thought to be much weaker than 2-fma and is compared to caffeine. This is pure unsubstantiated nonsense, 2-fa is a potent stimulant at only slightly higher doses compared to 2-fma. |
||
Line 19: | Line 19: | ||
==Subjective effects== | ==Subjective effects== | ||
In comparison to other substituted amphetamines, 2-FA is reported to be relatively free of side effects such as [[nausea]], [[high blood pressure]], [[anxiety]] and an uncomfortable [[offset]] ("comedown"). It is considered to be a functional and effective psychoactive substance for performing general productivity tasks in a manner that is similar to [[amphetamine|dextroamphetamine]]. However, at higher doses, it reportedly loses its productivity and attention-enhancing effects and begins to take on a recreational character due to the distracting euphoria and overstimulation that can result. However, it is often said that it possesses a "ceiling dose" that purportedly lowers the abuse threshold relative to methamphetamine, although this has yet to be scientifically demonstrated | In comparison to other substituted amphetamines, 2-FA is reported to be relatively free of side effects such as [[nausea]], [[high blood pressure]], [[anxiety]] and an uncomfortable [[offset]] ("comedown"). It is considered to be a functional and effective psychoactive substance for performing general productivity tasks in a manner that is similar to [[amphetamine|dextroamphetamine]]. However, at higher doses, it reportedly loses its productivity and attention-enhancing effects and begins to take on a recreational character due to the distracting euphoria and overstimulation that can result. However, it is often said that it possesses a "ceiling dose" that purportedly lowers the abuse threshold relative to methamphetamine, although this has yet to be scientifically demonstrated. | ||
{{Preamble/SubjectiveEffects}} | {{Preamble/SubjectiveEffects}} | ||
Line 97: | Line 97: | ||
{{#ask: [[Category:2-FA]][[Category:Experience]]|format=ul|Columns=1}} | {{#ask: [[Category:2-FA]][[Category:Experience]]|format=ul|Columns=1}} | ||
There are currently no anecdotal reports which describe the effects of this compound within our [[experience index]]. Additional experience reports can be found here: | There are currently no anecdotal reports which describe the effects of this compound within our [[experience index]]. Additional experience reports can be found here: | ||
* [https://www.erowid.org/experiences/subs/exp_2Fluoroamphetamine.shtml Erowid Experience Vaults: 2-FA] | |||
*[https://www.erowid.org/experiences/subs/exp_2Fluoroamphetamine.shtml Erowid Experience Vaults: 2-FA] | |||
==Toxicity and harm potential== | ==Toxicity and harm potential== | ||
Line 133: | Line 134: | ||
==See also== | ==See also== | ||
*[[Responsible use]] | *[[Responsible use]] | ||
*[[Designer drug]] | *[[Designer drug]] | ||
Line 143: | Line 145: | ||
==External links== | ==External links== | ||
*[https://en.wikipedia.org/wiki/2-Fluoroamphetamine 2-FA (Wikipedia)] | *[https://en.wikipedia.org/wiki/2-Fluoroamphetamine 2-FA (Wikipedia)] | ||
*[https://isomerdesign.com/PiHKAL/explore.php?id=2129 2-FA (Isomer Design)] | *[https://isomerdesign.com/PiHKAL/explore.php?id=2129 2-FA (Isomer Design)] |